JANX logo

Janux Therapeutics, Inc. (JANX) Working Capital

Annual Working Capital:

$1.02B+$680.00M(+202.26%)
December 31, 2024

Summary

  • As of today, JANX annual working capital is $1.02 billion, with the most recent change of +$680.00 million (+202.26%) on December 31, 2024.
  • During the last 3 years, JANX annual working capital has risen by +$651.99 million (+179.01%).
  • JANX annual working capital is now at all-time high.

Performance

JANX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

Quarterly Working Capital:

$984.17M-$21.66M(-2.15%)
June 30, 2025

Summary

  • As of today, JANX quarterly working capital is $984.17 million, with the most recent change of -$21.66 million (-2.15%) on June 30, 2025.
  • Over the past year, JANX quarterly working capital has increased by +$333.78 million (+51.32%).
  • JANX quarterly working capital is now -3.15% below its all-time high of $1.02 billion, reached on December 31, 2024.

Performance

JANX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

JANX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+202.3%+51.3%
3Y3 Years+179.0%+185.2%
5Y5 Years+10000.0%-

JANX Working Capital Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+221.7%-3.1%+237.7%
5Y5-Yearat high>+9999.0%-3.1%+7540.5%
All-TimeAll-Timeat high>+9999.0%-3.1%+7540.5%

JANX Working Capital History

DateAnnualQuarterly
Jun 2025
-
$984.17M(-2.2%)
Mar 2025
-
$1.01B(-1.0%)
Dec 2024
$1.02B(+202.3%)
$1.02B(+56.5%)
Sep 2024
-
$649.15M(-0.2%)
Jun 2024
-
$650.39M(+0.4%)
Mar 2024
-
$648.06M(+92.8%)
Dec 2023
$336.21M(+6.4%)
$336.21M(-1.3%)
Sep 2023
-
$340.72M(+16.9%)
Jun 2023
-
$291.40M(-4.5%)
Mar 2023
-
$305.29M(-3.4%)
DateAnnualQuarterly
Dec 2022
$315.93M(-13.3%)
$315.93M(-3.7%)
Sep 2022
-
$328.00M(-4.9%)
Jun 2022
-
$345.07M(-2.0%)
Mar 2022
-
$352.14M(-3.3%)
Dec 2021
$364.22M(+2727.6%)
$364.22M(-3.4%)
Sep 2021
-
$377.12M(-2.7%)
Jun 2021
-
$387.40M(+500.5%)
Mar 2021
-
$64.51M(+400.8%)
Dec 2020
$12.88M(+424.5%)
$12.88M
Dec 2019
-$3.97M
-

FAQ

  • What is Janux Therapeutics, Inc. annual working capital?
  • What is the all-time high annual working capital for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. annual working capital year-on-year change?
  • What is Janux Therapeutics, Inc. quarterly working capital?
  • What is the all-time high quarterly working capital for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. quarterly working capital year-on-year change?

What is Janux Therapeutics, Inc. annual working capital?

The current annual working capital of JANX is $1.02B

What is the all-time high annual working capital for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high annual working capital is $1.02B

What is Janux Therapeutics, Inc. annual working capital year-on-year change?

Over the past year, JANX annual working capital has changed by +$680.00M (+202.26%)

What is Janux Therapeutics, Inc. quarterly working capital?

The current quarterly working capital of JANX is $984.17M

What is the all-time high quarterly working capital for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high quarterly working capital is $1.02B

What is Janux Therapeutics, Inc. quarterly working capital year-on-year change?

Over the past year, JANX quarterly working capital has changed by +$333.78M (+51.32%)
On this page